Jill Reckless & Jon Heal - outsourcing drug development

<p>Jill Reckless, CEO and co-founder of RxCelerate, and Jon Heal, Head of In Silico Designs at RxCelerate, discuss the virtual biotech industry, outsourcing drug development, and using bioinformatics for target optimization. </p> <p>The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of biotechnology companies, with a focus on genomics.</p> <p>https://www.bioinformaticscro.com/</p>